Fanyue Meng - Concepedia

Concepedia

Author

Fanyue Meng

Jiangsu Provincial Center for Disease Control and Prevention

Also Known As

Fan-Yue Meng, Fanyue Meng, Meng Fanyue

56

Publications

1.8K

Citations

20

H-Index

52

Concepts

All Affiliations

Jiangsu Provincial Center for Disease Control and Prevention National Institutes for Food and Drug Control Southeast University Affiliated Hospital of Qingdao University Army Medical University

FM

About

Fanyue Meng is an author at Jiangsu Provincial Center for Disease Control and Prevention specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	751
2	Engineering	5	5	151
3	Allergy	2	2	38
4	Social Sciences	1	1	37
5	Biostatistics	1	1	21

Fanyue Meng

×

29

Publications

1.8K

Citations

19

H-Index

	Year	Citations
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Fengcai Zhu, Fanyue Meng, Jingxin Li, The Lancet VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2013	382
A Novel Influenza A (H1N1) Vaccine in Various Age Groups Fengcai Zhu, Hua Wang, Han-hua Fang, New England Journal of Medicine	2009	341
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial Fengcai Zhu, Lihua Hou, Jingxin Li, The Lancet VaccinationVaccine SafetyVaccine DevelopmentPreliminary ReportImmunology	2015	187
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial Jingxin Li, Lihua Hou, Fanyue Meng, The Lancet Global Health	2016	101
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial Fengcai Zhu, Zhenglun Liang, Xiuling Li, The Lancet VaccinationVaccine SafetyPlacebo-controlled Phase 2Vaccine DevelopmentImmunology	2013	87
Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants Fengcai Zhu, Zhenglun Liang, Fanyue Meng, PLoS ONE	2012	76
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study Mingwei Wei, Fanyue Meng, Shiyuan Wang, The Journal of Infectious Diseases	2016	65
Evaluation of wear mechanism between TC4 titanium alloys and self-lubricating fabrics Song Zhao, Fanyue Meng, Bingli Fan, Wear Materials ScienceEngineeringWear MechanismWear TestingWear Prevention	2022	49
Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children Fanyue Meng, Jingxin Li, Xiuling Li, Human Vaccines & Immunotherapeutics	2012	41
The cooling capacity of urban vegetation and its driving force under extreme hot weather: A comparative study between dry-hot and humid-hot cities Zhibin Ren, Chengcong Wang, Yüjie Guo, Building and Environment ClimatologyEngineeringDroughtGeographyUrban Heat Island	2024	37

Page 1